Updated May 2024

Our past work for opioid manufacturers, while lawful, fell short of the high standards we set for ourselves. We apologized for this past work and were the first company to work with U.S. State Attorneys General to help communities affected by the crisis. We have also reached agreements with political subdivisions, school districts, Native American tribes and third-party payors. The firm entered into these agreements, which contain no admissions of liability or wrongdoing, to avoid the time and expense of protracted litigation and support efforts to help those affected by the opioid epidemic.

In 2019, McKinsey committed to no longer advise clients on any opioid-related business anywhere in the world. More broadly, we have implemented a rigorous client selection policy and spent approximately $1 billion building, enhancing, and operating our risk, legal, and compliance functions since 2018.